Case report: Severe, symptomatic hypomagnesemia in acute leptospirosis

American Journal of Tropical Medicine and Hygiene

Volumn 79, Issue 6, 2008, Pages 915-917

  Spichler, Anne ^b,c   Athanazio, Daniel A ^d   Furtado, Juvencio ^e   Seguro, Antonio ^b,c   Vinetz, Joseph M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c INSTITUTO DE INFECTOLOGIA EMÍLIO RIBAS   (Brazil)

^d FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^e Heliopolis General Hospital   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; ADOLESCENT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; ELECTROLYTE BALANCE; FEMALE; HUMAN; HYPOMAGNESEMIA; LEPTOSPIROSIS; MAGNESIUM BLOOD LEVEL; SYMPTOM;

EID: 57649211311     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2008.79.915     Document Type: Article

References (16)

1. Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, Levett PN, Gilman RH, Willig MR, Gotuzzo E, Vinetz JM; Peru-United States Leptospirosis Consortium, 2003. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 3: 757-771.
2. Spichler A, Athanazio D, Buzzar M, Castro B, Chapolla E, Seguro A, Vinetz JM, 2007. Using death certificate reports to find severe leptospirosis cases, Brazil. Emerg Infect Dis 13: 1559-1561.
3. Seguro AC, Lomar AV, Rocha AS, 1990. Acute renal failure of leptospirosis: nonoliguric and hypokalemic forms. Nephron 55: 146-151.
4. Yang CW, Wu MS, Pan MJ, Hong JJ, Yu CC, Vandewalle A, Huang CC, 2000. Leptospira outer membrane protein activates NF-κB and downstream genes expressed in medullary thick ascending limb cells. J Am Soc Nephrol 11: 2017-2026.
5. Wu MS, Yang CW, Pan MJ, Chang CT, Chen YC, 2004. Reduced renal Na+-K+-Cl- co-transporter activity and inhibited NKCC2 mRNA expression by Leptospira shermani: from bed-side to bench. Nephrol Dial Transplant 19: 2472-2479.
6. Andrade L, Rodrigues AC Jr, Sanches TR, Souza RB, Seguro AC, 2006. Leptospirosis leads to dysregulation of sodium transporters in the kidney and lung. Am J Physiol Renal Physiol 292: F586-F592.
7. Spichler A, Ko AI, Silva EF, De Brito T, Silva AM, Athanazio D, Silva C, Seguro A, 2007. Reversal of renal tubule transporter down-regulation during severe leptospirosis with antimicrobial therapy. Am J Trop Med Hyg 77: 1111-1119.
8. de Jorge FB, 1970. Concentration of copper, ceruloplasmin, magnesium and sulfate in the blood of patients with a hepato-renal form of Weil's disease. Rev Bras Med 27: 449-451.
9. Khositseth S, Sudjaritjan N, Tananchai P, Ong-ajyuth S, Sitprija V, Thongboonkerd V, 2007. Renal magnesium wasting and tubular dysfunction in leptospirosis. Nephrol Dial Transplant 23: 952-958.
10. Berkelhammer C, Bear RA, 1985. A clinical approach to common electrolyte problems: 4. Hypomagnesemia. Can Med Assoc J 132: 360-368.
11. Gunnerson KJ, Kellum JA, 2003. Acid-base and electrolyte analysis in critically ill patients: are we ready for the new millennium? Curr Opin Crit Care 9: 468-473.
12. Tong GM, Rude RK, 2005. Magnesium deficiency in critical illness. J Intensive Care Med 20: 3-17.
13. Abdulkader RC, Seguro AC, Malheiro PS, Burdmann EA, Marcondes M, 1996. Peculiar electrolytic and hormonal abnormalities in acute renal failure due to leptospirosis. Am J Trop Med Hyg 54: 1-6.
14. Covic A, Goldsmith DJ, Gusbeth-Tatomir P, Seica A, Covic M, 2003. A retrospective 5-year study in Moldova of acute renal failure due to leptospirosis: 58 cases and a review of the literature. Nephrol Dial Transplant 18: 1128-1134.
15. Ko AI, Galvao Reis M, Ribeiro Dourado CM, Johnson WD Jr, Riley LW, 1999. Urban epidemic of severe leptospirosis in Brazil. Salvador Leptospirosis Study Group. Lancet 354: 820-825.
16. Esen S, Sunbul M, Leblebicioglu H, Eroglu C, Turan D, 2004. Impact of clinical and laboratory findings on prognosis in leptospirosis. Swiss Med Wkly 134: 347-352.